Thought Leader Management

Thought Leader Management

$1,995.00

Medical Affairs Launch Series (Module 2.3)

Thought Leader Management is the third module of the 10-part Medical Affairs Product Launch Series.This series is being updated in 2018 to include an additional 20 company teams’ data. The new module showcases innovative insights, best practices and benchmarks surrounding thought leader management activity start times, budgets, staffing, key performance indicators and resources that occur as part of medical affairs’ contributions to product launch strategy. In developing this module, Cutting Edge Information’s analysts collected surveys from and consulted with a series of medical affairs leaders at a number of top pharmaceutical, biotechnology and medical device companies.

  • Description
  • Additional information

Thought Leader Management 2.3: Medical Affairs Product Launch Series

Thought Leader Management 2.3 is the third module of the 10-part Medical Affairs Product Launch Series. This series is being updated in 2018 to include an additional 20 company teams’ data. The new module showcases innovative insights, best practices and benchmarks surrounding thought leader management activity start times, budgets, staffing, key performance indicators and resources that occur as part of medical affairs’ contributions to product launch strategy. In developing this module, Cutting Edge Information’s analysts collected surveys from and consulted with a series of medical affairs leaders at a number of top pharmaceutical, biotechnology and medical device companies.

  • Publication Date: April 2018
  • Pages: 72
  • Metrics: 200+ 
  • Figures: 45+

To learn more about the other modules in the Medical Affairs Product Launch Series and the benefits of subscribing to the entire series, click here.

REPORT FEATURES:

Identify key performance indicators (KPIs) used to define the value of thought leader development teams: It is not possible to link thought leader activities directly to profits. This module explores other metrics, including the number of thought leader relationships per lifecycle stage, used to determine thought leader teams’ effectiveness and productivity.

REASONS TO BUY:

Identify key performance indicators (KPIs) used to define the value of thought leader development teams: It is not possible to link thought leader activities directly to profits. This module explores other metrics, including the number of thought leader relationships per lifecycle stage, used to determine thought leader teams’ effectiveness and productivity.

TARGET AUDIENCE:

Life science company executives, directors, and managers involved in the following areas should consider purchasing this report:
– Medical affairs
– Thought leader development
– Key opinion leader management
– Thought leader segmentation
– External expert identification
– Medical science liaison (MSL) programs

CHAPTER EXAMPLE:

One valuable consideration concerning thought leader development activities is the starting time. Teams begin in varying lifecycle stages. Most surveyed teams start after Phase 2; only 25% of surveyed teams start their thought leader development activities before Phase 3 (Figure 1.3.1). Many companies do not start thought leader development before Phase 3 due to the much higher failure rate of drugs in earlier lifecycle phases.